ANTI-TUMOR MECHANISM OF IL-21 USED ALONE AND IN COMBINATION WITH 5-FLUOROURACIL IN VITRO ON HUMAN GASTRIC CANCER CELLS

被引:0
|
作者
Fu, Z. Q. [1 ]
Zhou, Q. [1 ]
Zhu, S. [1 ]
Liu, W. [1 ]
机构
[1] Shi Dong Hosp, Dept Gen Surg, Shiguang Rd 999, Shanghai 200438, Peoples R China
关键词
IL-21; 5-Fluorouracil; gastric cancer cell; anti-tumor mechanisms; C-MYC; BCL-2; P53; INTERLEUKIN-21; CHEMOTHERAPY; CYTOTOXICITY; EXPRESSIONS; LYMPHOMA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To study the effect and related mechanism of IL-21 alone and in combination with 5-Fluorouracil on the proliferation and growth, transferability, and apoptosis of gastric cancer cells, we cultivated gastric cancer cell SGC-7901 and created four experimental groups with varying concentrations of IL-21 and 5-Fluorouracil: IL-21 group (IL-21 100ng/ml), semi-combination group (5-Fluorouracil 25 mu g/ml+IL-21 100ng/ml), 5-Fluorouracil group (5-Fluorouracil 50 mu g/ml), and combination group (5-Fluorouracil 50 mu g/ml+IL-21 100ng/ml). The MTT (3-(4, 5)-dimethylthiahiazo (-z-y1)-3, 5-diphenytetrazoliumromide) assay was used to detect the inhibitory effect of each group on the proliferation and growth of gastric cancer cells. A scratch-wound assay was carried out to detect the inhibitory effect of each group on transferability. TUNEL assay was used to detect the effect of each group on the apoptosis of the gastric cancer cells, and Western blot was used to detect the expression of caspase-3, caspase-8, bcl-2, and c-myc, which are the proteins related to apoptosis, after the drug effect in each group. The results show that, compared to the 5-Fluorouracil group, the inhibitory effects after 24 h of the IL-21 group and the semi-combination group on SGC-7901 were weaker (P<0.001). However, if the effect lasted 48 h, then the inhibition in the semi-combination group had no significant difference compared to the 5-Fluorouracil group (P>0.05). The scarification test showed that all groups could inhibit the transferability of SGC-7901 and that the effect increased successively from the IL-21 group, the semi-combination group, the 5-Fluorouracil group, to the combination group. The TUNEL assay indicated that all groups could promote the apoptosis of SGC-7901. The percentage of cell apoptosis increased, and the Western blot showed that the expression of caspase-3, caspase-8, and c-myc, respectively, in the semi-combination group, the 5-Fluorouracil group, and the combination group increased successively and that the successive increasing of c-myc was the most significant. The expression of bc1-2 tended to decrease. In conclusion, IL-21 used alone and in combination with 5-Fluorouracil are anti-tumor mechanisms in SGC-7901.
引用
收藏
页码:619 / 625
页数:7
相关论文
共 50 条
  • [41] Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
    Li, Sanhong
    Tian, Jilai
    Zhang, Hongming
    Zhou, Shoubing
    Wang, Xiyong
    Zhang, Lei
    Yang, Jiapeng
    Zhang, Zhigang
    Ji, Zhenling
    APOPTOSIS, 2018, 23 (5-6) : 356 - 374
  • [42] Mechanism for enhanced anti-tumor effects of 5-fluorouracil (5FU) by celecoxib in an advanced colon cancer model: Argiogenesis, or 5FU metabolisms?
    Irie, Takanobu
    Tsujii, Masahiko
    Tsuji, Shingo
    Ishii, Shuji
    Yoshio, Toshiyuki
    Shinzaki, Shinichiro
    Egawa, Satoshi
    Nishida, Tsutomu
    Kakiuchi, Yoshimi
    Yasumaru, Masakazu
    Iijima, Hideki
    Murata, Hiroaki
    Kawano, Sunao
    Hayashi, Norio
    GASTROENTEROLOGY, 2006, 130 (04) : A581 - A581
  • [43] NEW MECHANISM OF ACTION OF THE CANCER CHEMOTHERAPEUTIC AGENT 5-FLUOROURACIL IN HUMAN-CELLS
    WURZER, JC
    TALLARIDA, RJ
    SIROVER, MA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (01): : 39 - 43
  • [44] In vitro anti-tumor activity in SGC-7901 human gastric cancer cells treated with dandelion extract
    Han, Hui
    Chen, Geng Zhen
    Zhou, Sheng Kang
    Xu, Rui Ru
    Wu, Cheng Liang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (01) : 65 - 70
  • [45] Modulation of Autophagy in Gastric Cancer Cells and Sensitization to 5-Fluorouracil by Combination Therapy with Se–FA Nanoparticles
    Elnaz Faghfuri
    Shahnaz Hosseinzadeh
    Amir Hossein Faghfouri
    Journal of Cluster Science, 2024, 35 : 975 - 982
  • [46] Antitumor effects of a cyclooxygenase-2 inhibitor, meloxicam, alone and in combination with radiation and/or 5-fluorouracil in cultured tumor cells
    Ayakawa, Shiho
    Shibamoto, Yuta
    Sugie, Chikao
    Ito, Masato
    Ogino, Hiroyuki
    Tomita, Natsuo
    Kumagai, Masaoki
    Murakami, Hiromi
    Sawa, Hiroki
    MOLECULAR MEDICINE REPORTS, 2009, 2 (04) : 621 - 625
  • [47] Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
    Naing, A.
    Papadopoulos, K. P.
    Autio, K. A.
    Ott, P. A.
    Patel, M. R.
    Wong, D. J.
    Falchook, G.
    Pant, S.
    Whiteside, M.
    Rasco, D.
    Patnaik, A.
    Bendell, J. C.
    Bauer, T. M.
    Colen, R. R.
    Hong, D.
    Van Vlasselaer, P.
    Brown, G. L.
    Oft, M.
    Tannir, N.
    Infante, J. R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
    Naing, Aung
    Pant, Shubham
    Infante, Jeffrey
    Papadopoulos, Kyriakos
    Autio, Karen
    Wong, Deborah
    Ott, Patrick
    Falchook, Gerald
    Patel, Manish
    Whiteside, Melinda
    Colen, Rivka
    Bendell, Johanna
    Bauer, Todd
    Janku, Filip
    Javle, Milind
    Tannir, Nixar
    Oft, Martin
    Chan, Ivan
    Rasco, Drew
    Hong, David
    Patnaik, Amita
    Moore, Kathen
    Korn, Michael
    Van-Vlasselaer, Peter
    Brown, Gail
    BJU INTERNATIONAL, 2016, 118 : 25 - 25
  • [49] Research on Anti-Tumor Nano-Particle with New Type 5-Fluorouracil on the Peritoneal Metastasis of Breast Cancer
    Xiao, Yujie
    Huang, Guilin
    Xiang, Yibo
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (07) : 1277 - 1283
  • [50] Computational analysis of 5-fluorouracil anti-tumor activity in colon cancer using a mechanistic pharmacokinetic/pharmacodynamic model
    Ma, Chenhui
    Almasan, Alex
    Gurkan-Cavusoglu, Evren
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (11)